Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition).

ABSTRACT: Non-muscle invasive bladder cancer (NMIBC) is a major type of bladder cancer with a high incidence worldwide, resulting in a great disease burden. Treatment and surveillance are the most important part of NIMBC management. In 2018, we issued "Treatment and surveillance for non-muscle-invasive bladder cancer in China: an evidence-based clinical practice guideline". Since then, various studies on the treatment and surveillance of NMIBC have been published. There is a need to incorporate these materials and also to take into account the relatively limited medical resources in primary medical institutions in China. Developing a version of guideline which takes these two issues into account to promote the management of NMIBC is therefore indicated. We formed a working group of clinical experts

SUBMITTER: Jin YH 

PROVIDER: S-EPMC9382792 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature